VIANEWS – The Innrs algorithm for artificial intelligence suggests a high likelihood of discovering tomorrow’s approximate price of Enphase Energy ENPH and AbbVie ABBV.
Via News regularly facts-checks this AI algorithm, which aims to predict the session prices and trend for financial assets over time.
Innrs offers A.I.-based statistics tools that can be used to assist investors in making decisions. Below is a table that lists the most accurate financial assets for predicting prices, sorted by their highest predicted accuracy.
Officials at Innrs claim that this tool assists investors in making better-informed financial decisions. It is allegedly used along with other pertinent financial information, and according to the trader strategy.
Via News will present the results of the algorithm precision in the next session.
| Financial Asset | Accuracy | Close Price | Prediction |
|---|---|---|---|
| Enphase Energy (ENPH) | 93.13% | $312.11 | ⇧ $314.27 |
| AbbVie (ABBV) | 89.04% | $154.78 | ⇧ $156.94 |
| International Business Machines (IBM) | 88.85% | $147.74 | ⇧ $150.43 |
| Visa (V) | 88.76% | $211.37 | ⇧ $215.71 |
| Kinder Morgan (KMI) | 88.75% | $18.42 | ⇩ $18.32 |
| Gilead Sciences (GILD) | 88.65% | $83.41 | ⇧ $85.26 |
| Genmab (GMAB) | 88.64% | $43.76 | ⇧ $44.64 |
| Johnson & Johnson (JNJ) | 88.59% | $176.19 | ⇧ $178.94 |
| Lumen Technologies (LUMN) | 88.46% | $5.88 | ⇧ $5.94 |
| Comcast Corporation (CMCSA) | 88.27% | $34.42 | ⇧ $35.67 |
| Cenovus Energy (CVE) | 88.09% | $20.22 | ⇩ $19.65 |
| STMicroelectronics (STM) | 88.02% | $38.22 | ⇧ $38.89 |
| American Airlines (AAL) | 87.99% | $14.01 | ⇩ $13.76 |
| Amkor Technology (AMKR) | 87.31% | $28.32 | ⇧ $29.82 |
| Geo Group (GEO) | 87.17% | $9.78 | ⇧ $9.81 |
| AMD (AMD) | 87.15% | $73.58 | ⇧ $77.22 |
| Generac Holdlings (GNRC) | 86.05% | $103.32 | ⇩ $99.12 |
| Fifth Third Bancorp (FITBI) | 84.26% | $25.47 | ⇧ $25.55 |
| AT&T (T) | 84.26% | $18.99 | ⇧ $19.23 |
| Twitter (TWTR) | 84.13% | $53.7 | ⇧ $54.29 |
| Rogers Communication (RCI) | 83.95% | $44.53 | ⇧ $45.45 |
| Biogen (BIIB) | 83.78% | $302.92 | ⇧ $309.97 |
| Broadridge Financial Solutions (BR) | 83.76% | $144.17 | ⇧ $147.34 |
| Merck (MRK) | 83.7% | $104.36 | ⇧ $105.66 |
| White Mountains Insurance Group (WTM) | 83.66% | $1335.79 | ⇧ $1364 |
| Eli Lilly and Company (LLY) | 83.44% | $361.8 | ⇧ $362.59 |
| TE Connectivity (TEL) | 83.28% | $126.67 | ⇧ $131.27 |
1. Enphase Energy (ENPH)
Shares of Enphase Energy jumped by a staggering 28.82% in from $242.28 to $312.11 at 18:21 EST on Friday, after four sequential sessions in a row of gains. NASDAQ is rising 0.01% to $11,146.06, after two sequential sessions in a row of losses.
Enphase Energy, Inc., along with its subsidiaries, design, develop, manufacture, and market home energy solutions to the solar photovoltaic sector in the United States. It offers a semiconductor-based microinverter that converts solar energy to individual modules. The software is combined with proprietary networking and software technology to offer energy control and monitoring services. The company also sells AC battery storage, Envoy communication gateway and Enlighten cloud-based monitor service. It sells solutions directly to homeowners and solar distributors. Enphase Energy, Inc., was founded in 2006 in Fremont, California.
Sales Growth
Enphase Energy has a sales increase of 69.8% in the current quarter, and 52.2% the following.
More news about Enphase Energy.
2. AbbVie (ABBV)
Shares of AbbVie rose 5.32% in from $146.96 to $154.78 at 18:21 EST on Friday, following the last session’s upward trend. NYSE is rising 0.56% to $15,309.77, after two sequential sessions in a row of losses.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Average Moving
AbbVie is worth more than its moving average over 50 days of $143.46, and its moving average over 200 days of $147.96.
Sales Growth
AbbVie’s sales growth for the next quarter is 6%.
Volatility
AbbVie last week’s and last month’s intraday variations averages were 0.33%, 0.18, and 1.24%, respectively.
AbbVie had the highest average volatility amplitudes at 0.72%, 1.12% and 1.24% respectively (last week),
More news about AbbVie.
3. International Business Machines (IBM)
Shares of International Business Machines rose by a staggering 13.79% in from $129.84 to $147.74 at 18:21 EST on Friday, after five consecutive sessions in a row of gains. NYSE is rising 0.56% to $15,309.77, after two sequential sessions in a row of losses.
International Business Machines Corporation offers integrated services and solutions worldwide. It operates in four segments, Software, Consulting and Infrastructure. Software offers a hybrid cloud platform as well as software solutions such Red Hat Enterprise Open-Source Solutions, software for automation, AIOps, management and integration; data and AI solutions; security software and services to protect identity, threat data, and identity. The segment offers transaction processing software to support clients’ on-premise and mission-critical workloads within the banking, airline, and retail sectors. The Consulting segment provides business transformation services including strategy, process design, operations, data, analytics and system integration; as well as technology consulting and services. Infrastructure provides both on-premises storage and cloud-based servers and storage for clients with mission-critical or regulated workloads. It also offers support services, solutions and services for hybrid cloud infrastructure. Leasing, financing and loan financing are all available in the Financing segment. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.
More news about International Business Machines.
4. Visa (V)
Shares of Visa rose by a staggering 14.1% in from $185.25 to $211.37 at 18:21 EST on Friday, after five consecutive sessions in a row of gains. NYSE is jumping 0.56% to $15,309.77, after two consecutive sessions in a row of losses.
Visa Inc. is a global payments technology company. It facilitates digital payments between consumers, merchants and financial institutions. VisaNet is a payment processing network which enables the authorization, clearing and settlement of payments. The company also offers platforms and card products. The company offers its services under Visa Electron and PLUS brand names. Visa Inc. and Ooredoo have a strategic partnership to offer enhanced payments for Visa cardholders in Qatar. Visa Inc. was established in 1958 in San Francisco, California.
Moving Average
Visa’s worth is higher than its 50-day moving average of $206.02 and higher than its 200-day moving average of $209.96.
Sales Growth
The current quarter’s growth in sales for Visa is 15%
Previous days news about Visa
- Visa CEO al kelly to step down in February, ryan mcinerney named new CEO. According to MarketWatch on Thursday, 17 November, "McInerney views Visa founder Dee Hock, who died over the summer at 93, as an "inspiration. ", "Kelly, who’s been with Visa in the CEO role since late 2016, said the timing of the change was right for him in a number of ways, as he’s soon to turn 65 and has a "lot of energy" to move into the next chapter of his life. "
- Visa says ryan mcinerney will replace al kelly as its next CEO. According to CNBC on Thursday, 17 November, "McInerney has been president at Visa since 2013, overseeing the firm’s financial institutions, acquirers, merchants and partners.", "Ryan has boundless energy and passion for this business and in his role as President, and as my close partner for the past six years, he has become intimately familiar with how Visa operates and the exciting opportunities this industry presents," Kelly said in a statement."
More news about Visa.
5. Kinder Morgan (KMI)
Shares of Kinder Morgan jumped 5.26% in from $17.5 to $18.42 at 18:21 EST on Friday, after two sequential sessions in a row of losses. NYSE is jumping 0.56% to $15,309.77, after two sequential sessions in a row of losses.
Kinder Morgan, Inc. is an American energy infrastructure company. It operates in four main segments, Natural Gas Pipelines (Product Pipelines), Terminals and CO2. Natural Gas Pipelines is responsible for operating interstate and intrastate natural gaz pipelines, underground storage systems, natural gas processing facilities, natural gas gathering systems, natural gas treatment facilities, natural gas treating and treating facilities, natural gas liquids fractionation and transportation systems. It also owns and operates liquefied natural gases liquefaction facilities and storage facilities. Products Pipelines is a segment that owns refined petroleum products and crude oil and condensate pipes; as well as associated product terminals, petroleum pipeline transmix facilities and other related equipment. Terminals owns or operates bulk and liquid terminals for handling various commodities such as gasoline, diesel fuel and chemicals. It also owns tanksers. The CO2 segment manufactures, transports, markets, and stores CO2 for recovery and production of crude oil from mature fields. It also owns or operates crude oil processing plants and oil fields. The company owns or operates 83,000 mile of pipelines, and has 143 terminals. Kinder Morgan Holdco LLC was the company’s previous name. In February 2011, it changed its name from Kinder Morgan, Inc. Kinder Morgan, Inc. was established in Houston, Texas in 1936.
Sales Growth
Kinder Morgan’s sales growth is 10.1% for the present quarter and 33.3% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 14.8% and a drop 3.1% for the next.
Moving Average
Kinder Morgan is worth more than its moving average for 50 days of $17.65, and higher than its moving average for 200 days of $18.04.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Kinder Morgan’s stock is considered to be overbought (>=80).
More news about Kinder Morgan.
6. Gilead Sciences (GILD)
Shares of Gilead Sciences rose by a staggering 25.66% in from $66.38 to $83.41 at 18:21 EST on Friday, following the last session’s upward trend. NASDAQ is rising 0.01% to $11,146.06, after two successive sessions in a row of losses.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.7%, now sitting on 27.52B for the twelve trailing months.
Growth Estimates Quarters
For the current quarter, the company expects to grow by 101.4% while it will see a decrease of 24.1% in the following.
Moving Average
Gilead Sciences’s worth is way above its 50-day moving average of $68.68 and way above its 200-day moving average of $63.59.
More news about Gilead Sciences.
7. Genmab (GMAB)
Shares of Genmab jumped by a staggering 16.91% in from $37.43 to $43.76 at 18:21 EST on Friday, following the last session’s downward trend. NASDAQ is jumping 0.01% to $11,146.06, after two sequential sessions in a row of losses.
Genmab A/S is a Danish company that develops and markets antibody therapies for cancer treatment. DARZALEX is a monoclonal human antibody that can be used to treat multiple myeloma. Teprotumumab is for treatment of thyroid disease. Ofatumurnab (a human monoclonal anti-body for chronic lymphocyticleukemia (CLL), multiple sclerosis) and Amivantamab (for advanced, metastatic, or esophageal, cancers and NSCLC) are also available. Daratumumab is used to treat MM and non-MM blood tumors and AL Amyloidosis. The company also produces products. Phase 2 includes Teclistamab to treat vaso-occlusive crisis; Camidanlumab tesirine for treatment of hodgkin lymphoma; JNJ-64407564 for treatment of MM; PRV-015 to treat celiac disorder; Mim8 to treat haemophilia; and Lu AF82422 to treat multiple system atrophy. It also has 20 preclinical trials. Seagen Inc. has granted the company a collaboration and commercial license to develop tisotumab. The company also has a partnership agreement with CureVac AG to research and develop differentiated mRNA-based antibodies products. AbbVie is responsible for developing epcoritamab. There are collaborations with BioNTech, Janssen, Novo Nordisk A/S, Bolt Biotherapeutics, Inc. Genmab A/S was established in 1999. Its headquarters is in Copenhagen, Denmark.
Moving Average
Genmab is worth a lot more than its moving average for 50 days of $36.56 (and its moving average for 200 days of $34.40).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 492.6% and 1252.9%, respectively.
Annual Top and Bottom Value
Genmab stock’s value is $43.76 as of 18:22 EST. This is higher than the 52-week peak of $43.62.
More news about Genmab.
8. Johnson & Johnson (JNJ)
Shares of Johnson & Johnson jumped 5.76% in from $166.59 to $176.19 at 18:21 EST on Friday, after four sequential sessions in a row of gains. NYSE is rising 0.56% to $15,309.77, after two consecutive sessions in a row of losses.
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Moving Average
Johnson & Johnson’s worth is higher than its 50-day moving average of $166.88 and higher than its 200-day moving average of $172.14.
More news about Johnson & Johnson.
9. Lumen Technologies (LUMN)
Shares of Lumen Technologies fell by a staggering 13.27% in from $6.78 to $5.88 at 18:21 EST on Friday, after two successive sessions in a row of gains. NYSE is rising 0.56% to $15,309.77, after two sequential sessions in a row of losses.
Lumen Technologies, Inc., a facilities-based technology and communications company, provides various integrated products and services under the Lumen, Quantum Fiber, and CenturyLink brands to business and residential customers in the United States and internationally. The company operates in two segments, Business and Mass Markets. It offers compute and application services, such as cloud services, IT solutions, unified communication and collaboration solutions, colocation and data center services, content delivery services, and managed security services; and IP and data services, including VPN data network, Ethernet, internet protocol (IP), and voice over internet protocol. The company also provides fiber infrastructure services comprising high bandwidth optical wavelength networks; and unlit optical fiber and related professional services. In addition, it offers voice and other services, including private line services, a direct circuit or channel specifically dedicated for connecting two or more organizational sites; a portfolio of traditional time division multiplexing voice services; and synchronous optical network-based Ethernet, legacy data hosting services, and conferencing services. As of December 31, 2021, the company served approximately 4.5 million broadband subscribers. The company was formerly known as CenturyLink, Inc. and changed its name to Lumen Technologies, Inc. in September 2020. Lumen Technologies, Inc. was incorporated in 1968 and is headquartered in Monroe, Louisiana.
Revenue Growth
Year-on-year quarterly revenue growth declined by 5.4%, now sitting on 19.69B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Lumen Technologies’s stock is considered to be overbought (>=80).
Volatility
Lumen Technologies’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.91%, a negative 1.14%, and a positive 2.90%.
Lumen Technologies’s highest amplitude of average volatility was 2.91% (last week), 3.26% (last month), and 2.90% (last quarter).
Sales Growth
Lumen Technologies’s sales growth is negative 6.8% for the current quarter and negative 8.1% for the next.
More news about Lumen Technologies.
10. Comcast Corporation (CMCSA)
Shares of Comcast Corporation rose by a staggering 11.68% in from $30.82 to $34.42 at 18:21 EST on Friday, following the last session’s upward trend. NASDAQ is jumping 0.01% to $11,146.06, after two successive sessions in a row of losses.
Comcast Corporation operates as a media and technology company worldwide. It operates through Cable Communications, Media, Studios, Theme Parks, and Sky segments. The Cable Communications segment offers broadband, video, voice, wireless, and other services to residential and business customers under the Xfinity brand; and advertising services. The Media segment operates NBCUniversal's television and streaming platforms, including national, regional, and international cable networks, the NBC and Telemundo broadcast, and Peacock networks. The Studios segment operates NBCUniversal's film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida; Hollywood, California; Osaka, Japan; and Beijing, China. The Sky segment offers direct-to-consumer services, such as video, broadband, voice and wireless phone services, and content business operates entertainment networks, the Sky News broadcast network, and Sky Sports networks. The company also owns the Philadelphia Flyers, as well as the Wells Fargo Center arena in Philadelphia, Pennsylvania; and provides streaming service, such as Peacock. Comcast Corporation was founded in 1963 and is headquartered in Philadelphia, Pennsylvania.
More news about Comcast Corporation.
11. Cenovus Energy (CVE)
Shares of Cenovus Energy jumped by a staggering 19.29% in from $16.95 to $20.22 at 18:21 EST on Friday, after two sequential sessions in a row of losses. NYSE is rising 0.56% to $15,309.77, after two consecutive sessions in a row of losses.
Cenovus Energy Inc. and its affiliates develop, produce, and market crude oil and natural gas liquids in Canada, the United States and the Asia Pacific. Oil Sands, Conventional and Offshore, Canadian Manufacturing (U.S. Manufacturing), Retail, and Oil Sands segments are the company’s main operations. Oil Sands produces bitumen in Saskatchewan and northern Alberta. These segments include Foster Creek, Christina Lake and Tucker oil-sands projects as well Lloydminster thermal assets and conventional heavy oils assets. The Conventional segment consists of assets located primarily in Elmworth-Wapiti and Kaybob-Edson. Clearwater and Rainbow Lake operate in Alberta and British Columbia. It also has interests in natural gas processing plants. Offshore activities include exploration and development. Canadian Manufacturing includes the Lloydminster upgrading, asphalt refining and upgrading complex. This converts heavy oil and bitumen to synthetic crude oil, diesel oil, asphalt and other ancillary products. It also owns and runs the Bruderheim crude by rail terminal and two ethanol production plants. U.S. Manufacturing includes the refinement of crude oil for diesel, gasoline and jet fuel as well as asphalt production. It markets its own refined petroleum products and those of third parties through wholesale, retail, bulk, and commercial outlets. Cenovus Energy Inc. is located in Calgary, Canada.
Sales Growth
Cenovus Energy’s sales growth is 14.3% for the present quarter and 6.8% for the next.
More news about Cenovus Energy.
12. STMicroelectronics (STM)
Shares of STMicroelectronics jumped by a staggering 14.81% in from $33.29 to $38.22 at 18:21 EST on Friday, after two consecutive sessions in a row of gains. NYSE is rising 0.56% to $15,309.77, after two consecutive sessions in a row of losses.
STMicroelectronics N.V. and its subsidiaries design, develop, manufacture, and market semiconductor products throughout Europe, Africa, Asia Pacific, Africa, Americas and the Middle East. It operates in three segments: Automotive and Discrete Group, Analog MEMS and Sensors Group and Microcontrollers and Digital ICs Group. Automotive and Discrete Group offers integrated circuits for automobiles, as well as discrete and power transistors. The Analog, MEMS and Sensors Group segment provides industrial application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs); general purpose analog products; custom analog ICs; wireless charging solutions; galvanic isolated gate drivers; low and high voltage amplifiers, comparators, and current-sense amplifiers; MasterGaN, a solution that integrates a silicon driver and GaN power transistors in a single package; wireline and wireless connectivity ICs; touch screen controllers; micro-electro-mechanical systems (MEMS) products, including sensors or actuators; and optical sensing solutions. Microcontrollers and Digital ICs Group offers general-purpose and secure microcontrollers, radio frequency (RF), and electrically erasable programmable memory read-only memories, as well as RF, mixed-signal and digital ASICs. The company also offers assembly services. It sells products via distributors, retailers and sales reps. The company serves the automotive, computer and peripherals, as well as industrial and personal electronic and communication equipment markets. STMicroelectronics N.V. is an international corporation that was founded in 1987. Its headquarters are in Geneva, Switzerland.
Growth Estimates Quarters
For the current quarter, the company expects to grow by 68.6% and 8.5% respectively.
Revenue growth
Annual revenue growth was 28.2% year-over-year. The twelve trailing months saw 14.14B in revenues.
Classification of Stock Prices
The stochastic oscillator is a helpful indicator for overbought or oversold situations.
STMicroelectronics is overbought by more than 80.
More news about STMicroelectronics.
13. American Airlines (AAL)
Shares of American Airlines jumped 6.14% in from $13.2 to $14.01 at 18:21 EST on Friday, after five sequential sessions in a row of losses. NASDAQ is rising 0.01% to $11,146.06, after two sequential sessions in a row of losses.
American Airlines Group Inc. operates through its subsidiaries as a network airline carrier. It provides cargo and passenger scheduled air transport services through its hubs at Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, Washington, D.C., along with partner gateways in London, Madrid, Seattle/Tacoma, Sydney, Tokyo, and Sydney. It had a fleet of mainline aircraft of 865 as of December 31, 2021. The original name of the company was AMR Corporation. In December 2013, American Airlines Group Inc. took over its operations. American Airlines Group Inc. was established in Fort Worth in Texas in 1930.
Classification of Stock Prices
The stochastic oscillator is a helpful indicator for overbought or oversold situations.
American Airlines stock is overbought (>=80).
Sales Growth
American Airlines saw a 34.7% increase in sales for its current quarter, and 31.9% the following.
Growth Estimates Quarters
For the current quarter, the company expects to grow by 140.1% and 90% respectively.
More news about American Airlines.
14. Amkor Technology (AMKR)
Shares of Amkor Technology jumped by a staggering 59.1% in from $17.8 to $28.32 at 18:21 EST on Friday, following the last session’s upward trend. NASDAQ is rising 0.01% to $11,146.06, after two successive sessions in a row of losses.
Amkor Technology, Inc. offers outsourced semiconductor packaging services and testing in America, Japan, Europe, Africa, Europe, Middle East, Africa, and other parts of Asia Pacific. The company offers turnkey packaging services and testing services including wafer bumping, wafer probe and wafer back-grind. It also provides package design, packaging, test, drop shipping, and packaging services. Flip chip-scale packaging products are available for smartphones and tablets. It also offers flip-chip stack chip-scale packages, which can be used to stack digital baseband memory and applications processors on mobile devices. The flip-chip ball grid array package is for different networking, storage and computing applications. It also offers wafer level CSP packages, that can be used in power management and transceivers. Further, the company provides lead frame packages that are used in electronic devices for low to medium pin count analog and mixed-signal applications; substrate-based wirebond packages, which are used to connect a die to a substrate; micro-electro-mechanical systems (MEMS) packages that are miniaturized mechanical and electromechanical devices; and advanced system-in-package modules, which are used in radio frequency and front end modules, basebands, connectivity, fingerprint sensors, display and touch screen drivers, sensors and MEMS, and NAND memory and solid-state drives. The company serves many different markets, including original equipment producers, contract foundries, integrated device makers, fabless semiconductor firms, contract manufacturers and original equipment suppliers. Amkor Technology, Inc., was established in 1968. It is located in Tempe, Arizona.
Moving Average
Amkor Technology’s market value is much higher than the 50-day moving mean of $19.04, and far above its 200 day moving average $19.91.
Volatility
Amkor Technology’s last week, last month’s, and last quarter’s current intraday variation average was 3.40%, 2.17%, and 2.39%.
Amkor Technology’s highest amplitude of average volatility was 4.33% (last week), 2.79% (last month), and 2.39% (last quarter).
Growth Estimates Quarters
For the current quarter, the company expects to grow by 42.9% while predicting a decline of 23.2% in the following.
More news about Amkor Technology.
15. Geo Group (GEO)
Shares of Geo Group jumped by a staggering 14.25% in from $8.56 to $9.78 at 18:21 EST on Friday, after five consecutive sessions in a row of gains. NYSE is jumping 0.56% to $15,309.77, after two sequential sessions in a row of losses.
The GEO Group, Inc. (NYSE: GEO) is a leading diversified government service provider, specializing in design, financing, development, and support services for secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO's diversified services include enhanced in-custody rehabilitation and post-release support through the award- winning GEO Continuum of Care, secure transportation, electronic monitoring, community-based programs, and correctional health and mental health care. GEO's worldwide operations include the ownership and/or delivery of support services for 102 facilities totaling approximately 82,000 beds, including idle facilities and projects under development, with a workforce of up to approximately 18,000 employees.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Geo Group’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
Geo Group’s stock is valued at $9.78 at 18:22 EST, below its 52-week high of $9.81 and way higher than its 52-week low of $5.21.
More news about Geo Group.
16. AMD (AMD)
Shares of AMD jumped by a staggering 25.31% in from $58.72 to $73.58 at 18:21 EST on Friday, following the last session’s upward trend. NASDAQ is rising 0.01% to $11,146.06, after two consecutive sessions in a row of losses.
Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. The company operates in two segments, Computing and Graphics; and Enterprise, Embedded and Semi-Custom. Its products include x86 microprocessors as an accelerated processing unit, chipsets, discrete and integrated graphics processing units (GPUs), data center and professional GPUs, and development services; and server and embedded processors, and semi-custom System-on-Chip (SoC) products, development services, and technology for game consoles. The company provides processors for desktop and notebook personal computers under the AMD Ryzen, AMD Ryzen PRO, Ryzen Threadripper, Ryzen Threadripper PRO, AMD Athlon, AMD Athlon PRO, AMD FX, AMD A-Series, and AMD PRO A-Series processors brands; discrete GPUs for desktop and notebook PCs under the AMD Radeon graphics, AMD Embedded Radeon graphics brands; and professional graphics products under the AMD Radeon Pro and AMD FirePro graphics brands. It also offers Radeon Instinct, Radeon PRO V-series, and AMD Instinct accelerators for servers; chipsets under the AMD trademark; microprocessors for servers under the AMD EPYC; embedded processor solutions under the AMD Athlon, AMD Geode, AMD Ryzen, AMD EPYC, AMD R-Series, and G-Series processors brands; and customer-specific solutions based on AMD CPU, GPU, and multi-media technologies, as well as semi-custom SoC products. It serves original equipment manufacturers, public cloud service providers, original design manufacturers, system integrators, independent distributors, online retailers, and add-in-board manufacturers through its direct sales force, independent distributors, and sales representatives. The company was incorporated in 1969 and is headquartered in Santa Clara, California.
More news about AMD.
17. Generac Holdlings (GNRC)
Shares of Generac Holdlings fell 6.19% in from $110.14 to $103.32 at 18:21 EST on Friday, after four consecutive sessions in a row of losses. NYSE is jumping 0.56% to $15,309.77, after two sequential sessions in a row of losses.
Generac Holdings Inc. designs, manufactures, and sells power generation equipment, energy storage systems, and other power products for the residential, and light commercial and industrial markets worldwide. The company offers engines, alternators, batteries, electronic controls, steel enclosures, and other components. It also provides residential automatic standby generators ranging in output from 7.5kW to 150kW; air-cooled engine residential standby generators ranging from 7.5kW to 26kW; liquid-cooled engine generators with outputs ranging from 22kW to 150kW; and Mobile Link, a remote monitoring system for home standby generators. In addition, the company offers various portable generators ranging in size from 800W to 17.5kW; outdoor power equipment, such as trimmers, field and brush mowers, log splitters, stump grinders, chipper shredders, lawn and leaf vacuums, pressure washers, and water pumps; and clean energy solution under the PWRcell and PWRview brands. Further, it provides light towers, mobile generators, and mobile energy storage systems; commercial mobile pumps and dust-suppression equipment; various gaseous-engine control systems and accessories; light-commercial standby generators ranging from 22kW to 150kW and related transfer switches providing three-phase power for small and mid-sized businesses; and industrial generators ranging in output from 10kW to 3,250kW used as emergency backup for healthcare, telecom, datacom, commercial office, retail, municipal, and manufacturing markets. Additionally, the company sells aftermarket service parts and product accessories to dealers. It distributes its products through independent residential dealers, industrial distributors and dealers, national and regional retailers, e-commerce partners, electrical, HVAC and solar wholesalers, catalogs, equipment rental companies and distributors, and solar installers; and directly to end users. The company was founded in 1959 and is headquartered in Waukesha, Wisconsin.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 9.6% and 36.6%, respectively.
Sales Growth
Generac Holdlings’s sales growth is 37.5% for the ongoing quarter and 41.3% for the next.
Classification of Stock Prices
The stochastic oscillator is a helpful indicator for overbought or oversold situations.
Generac Holdings is overbought (>=80).
More news about Generac Holdlings.
18. Fifth Third Bancorp (FITBI)
Shares of Fifth Third Bancorp rose 3.08% in from $24.71 to $25.47 at 18:21 EST on Friday, following the last session’s downward trend. NASDAQ is rising 0.01% to $11,146.06, after two consecutive sessions in a row of losses.
Fifth Third is a bank that's as long on innovation as it is on history. Since 1858, we've been helping individuals, families, businesses and communities grow through smart financial services that improve lives. Our list of firsts is extensive, and it's one that continues to expand as we explore the intersection of tech-driven innovation, dedicated people, and focused community impact. Fifth Third is one of the few U.S.-based banks to have been named among Ethisphere's World's Most Ethical Companies® for several years. With a commitment to taking care of our customers, employees, communities and shareholders, our goal is not only to be the nation's highest performing regional bank, but to be the bank people most value and trust. Fifth Third Bank, National Association is a federally chartered institution. Fifth Third Bancorp is the indirect parent company of Fifth Third Bank and its common stock is traded on the NASDAQ® Global Select Market under the symbol “FITB.” Investor information and press releases can be viewed at www.53.com.
Revenue growth
The year-on-year revenue growth for quarterly declined 11.1%. We now have 7.8B in the 12 trailing months.
Volatility
Fifth Third Bancorp last week’s and last month’s intraday variation averages were negative 0.19, 0.10% and 0.70% respectively.
Fifth Third Bancorp had the highest average volatility amplitude at 0.89%, 0.99% and 0.70% respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Fifth Third Bancorp’s stock is considered to be oversold (<=20).
More news about Fifth Third Bancorp.
19. AT&T (T)
Shares of AT&T rose by a staggering 24.04% in from $15.31 to $18.99 at 18:21 EST on Friday, after two consecutive sessions in a row of gains. NYSE is jumping 0.56% to $15,309.77, after two sequential sessions in a row of losses.
AT&T Inc. offers telecommunications and media services around the world. The Communications segment provides wireless voice and data communication services. It also sells wireless devices and accessories through third-party retailers, agent stores and company stores. The company also offers managed and professional services and data, voice and security solutions. This segment also offers voice communications services via legacy telephony and broadband fiber to residential customers. The company markets its communication services and products under AT&T’s Cricket, AT&T PREPAID and AT&T Fiber brands. Latin America is the company’s segment that provides services for wireless in Mexico and video in Latin America. The Unefon and AT&T brands are used to market the services and products of this segment. The company used to be known as SBC Communications Inc., but changed its name in 2005 to AT&T Inc. AT&T Inc. was founded in 1983. It is located in Dallas, Texas.
Growth Estimates Quarters
For the current quarter, the company expects a decline of 26.9% in growth and for the next one, a decrease of 16.9% respectively.
Yearly Top and Bottom Value
AT&T’s stock is valued at $18.99 at 18:23 EST, way below its 52-week high of $21.53 and way higher than its 52-week low of $14.46.
Moving Average
AT&T’s worth is way above its 50-day moving average of $16.73 and higher than its 200-day moving average of $18.49.
More news about AT&T.
20. Twitter (TWTR)
Shares of Twitter jumped 7.46% in from $49.97 to $53.70 at 18:21 EST on Friday, following the last session’s downward trend. NYSE is rising 0.56% to $15,309.77, after two consecutive sessions in a row of losses.
Twitter, Inc. is a social media platform that allows people to express themselves and have real-time conversations. Twitter is the company’s main product. It allows people to create, consume, distribute and discover content. The company also offers promoted products which allow advertisers to advertise brands, products and services. The company’s promoted products include Twitter Amplify and Follower Ads as well as promoted ads. The company also offers monetization products to creators. These include Tips, which allows creators to send one-off small payments to Twitter via various payment methods including bitcoin. Super Follows is a monthly paid subscription that includes bonus content and previews. Ticketed Spaces supports creators by paying them for hosting and managing the Twitter Spaces public discussion. It also offers data partners and products to developers, including the Twitter Developer Platform. This platform allows developers to create tools for businesses and people using its public API. Partners with commercial uses of Twitter data can get paid access to Twitter data. Twitter, Inc. was established in 2006 in San Francisco, California.
Sales Growth
Twitter is forecast to grow its sales by 0.6% in the next quarter.
Revenue growth
The year-over-year revenue growth fell by 1.2%. We now have 5.23B in the 12 trailing months.
More news about Twitter.
21. Rogers Communication (RCI)
Shares of Rogers Communication rose by a staggering 16.66% in from $38.17 to $44.53 at 18:21 EST on Friday, after two sequential sessions in a row of gains. NYSE is jumping 0.56% to $15,309.77, after two successive sessions in a row of losses.
Rogers Communications Inc. is a Canadian communications and media company. The company operates in three areas: Wireless, Cable, and Media. It offers wireless Internet access, voice and enhanced voice, accessory and device financing, mobile Internet, wired voice and wireless voice, home phone and device protection, wireless device, global voice, data roaming and bridging landline. The company also offers Internet and WiFi services and smart home monitoring services. These include monitoring, security and automation as well as energy efficiency and smart control via a smartphone application. The company also offers on-demand and local TV, cloud-based digital video recorders, voice-activated remote control, and integrated apps, personal video recorders, linear and time-shifted programming, digital specialty channels, 4K TV programming, and televised content for smartphones, tablets, or personal computers. It also operates Ignite TV, Ignite TV App, and Ignite TV. It also offers residential and small-business local telephony services. It also holds the Toronto Blue Jays team and Rogers Centre venue. The company operates Sportsnet ONE and Sportsnet 360 television networks. OLN radio stations, 55 AM and FM radio stations, and Sportsnet 360. It was established in Canada in 1960.
Moving Average
Rogers Communication’s value exceeds its $50.52 moving average and is below its $200 moving average $48.15.
More news about Rogers Communication.
22. Biogen (BIIB)
Shares of Biogen rose by a staggering 13.19% in from $267.62 to $302.92 at 18:21 EST on Friday, after four sequential sessions in a row of gains. NASDAQ is rising 0.01% to $11,146.06, after two consecutive sessions in a row of losses.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for treating relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it develops BIIB135, BIIB061, BIIB091, and BIIB107 for MS and neuroimmunology; Aducanumab, Lecanemab, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB105, BIIB100, and BIIB110 to treat neuromuscular disorders; BIIB124, BIIB094, BIIB118, BIIB101, and BIIB122 for treating Parkinson's disease and movement disorders; BIIB125 and BIIB104 for treating neuropsychiatry; Dapirolizumab pegol and BIIB059 to treat immunology related diseases; BIIB093 and BIIB131 to treat acute neurology; BIIB074 for neuropathic pain; and BYOOVIZ, BIIB800, and SB15 biosimilars, which are under various stages of development. The company has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Sales Growth
Biogen sales growth was negative 10.5% in the most recent quarter, and negative 7.9% in the following.
Revenue growth
The year-on-year revenue growth fell by 9.7%. Now, the 12. trailing months are worth 10.36 billion.
Volatility
Biogen’s last week, last month’s, and last quarter’s current intraday variation average was 1.08%, 0.34%, and 2.06%.
Biogen’s highest amplitude of average volatility was 1.08% (last week), 1.23% (last month), and 2.06% (last quarter).
More news about Biogen.
23. Broadridge Financial Solutions (BR)
Shares of Broadridge Financial Solutions rose 0.97% in from $142.78 to $144.17 at 18:21 EST on Friday, after two consecutive sessions in a row of losses. NYSE is rising 0.56% to $15,309.77, after two consecutive sessions in a row of losses.
Broadridge Financial Solutions, Inc. provides investor communications and technology-driven solutions for the financial services industry. The company's Investor Communication Solutions segment processes and distributes proxy materials to investors in equity securities and mutual funds, as well as facilitates related vote processing services; and distributes regulatory reports, class action, and corporate action/reorganization event information, as well as tax reporting solutions. It also offers ProxyEdge, an electronic proxy delivery and voting solution; data-driven solutions and an end-to-end platform for content management, composition, and omni-channel distribution of regulatory, marketing, and transactional information, as well as mutual fund trade processing services; data and analytics solutions; solutions for public corporations and mutual funds; SEC filing and capital markets transaction services; registrar, stock transfer, and record-keeping services; and omni-channel customer communications solutions, as well as operates Broadridge Communications Cloud platform that creates, delivers, and manages communications and customer engagement activities. The company's Global Technology and Operations segment provides solutions that automate the front-to-back transaction lifecycle of equity, mutual fund, fixed income, foreign exchange and exchange-traded derivatives, order capture and execution, trade confirmation, margin, cash management, clearance and settlement, reference data management, reconciliations, securities financing and collateral management, asset servicing, compliance and regulatory reporting, portfolio accounting, and custody-related services. This segment also offers business process outsourcing services; technology solutions, such portfolio management, compliance, fee billing, and operational support solutions; and capital market and wealth management solutions. The company was founded in 1962 and is headquartered in Lake Success, New York.
Growth Estimates Quarters
For the current quarter, the company expects to grow by 20.1% while it will drop 6.5% in the following.
Volatility
Broadridge Financial Solutions last week’s and last month’s intraday variation averages were positive 0.56% and negative 0.25% respectively.
Broadridge Financial Solutions had the highest average volatility amplitudes of 0.64%, 1.55% and 1.46% in the last quarter.
Annual Top and Bottom Value
Broadridge Financial Solutions stock was valued at $144.17 as of 18:23 EST. This is lower than its 52 week high of $185.40, and higher than its 52-week lowest of $131.35.
More news about Broadridge Financial Solutions.
24. Merck (MRK)
Shares of Merck jumped by a staggering 10.88% in from $94.12 to $104.36 at 18:21 EST on Friday, after two sequential sessions in a row of gains. NYSE is jumping 0.56% to $15,309.77, after two successive sessions in a row of losses.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Annual Top and Bottom Value
Merck stock was valued at $104.36 as of 18:23 EST at an increase above the 52-week peak of $103.76.
More news about Merck.
25. White Mountains Insurance Group (WTM)
Shares of White Mountains Insurance Group dropped 2.27% in from $1366.82 to $1,335.79 at 18:21 EST on Friday, after two successive sessions in a row of losses. NYSE is rising 0.56% to $15,309.77, after two successive sessions in a row of losses.
White Mountains Insurance Group, Ltd., and its affiliates, provide insurance and financial services throughout the United States. Five segments make up the company: HG Global/BAM (arch), NSM, Kudu and Other Operations. The HG Global/BAM Segment provides insurance for municipal bonds that are issued for public purposes such as transportation, schools and utilities. The Ark segment is responsible for writing a range of reinsurance products and insurance. This includes property, marine, energy, accident, health, casualty and specialty products. NSM serves as the managing general agent for special property and casualty insurance. It covers a variety of sectors including specialty transport, real estate and social services. Kudu provides capital solutions for boutique asset managers, including management buyouts, acquisitions, growth finance, legacy partner liquidity and generational ownership transfer. Other Operations offers travel insurance through a broker channel or direct to consumers. It manages separate accounts as well as pooled investments vehicles and pools for the insurance-linked sectors. This includes catastrophe bonds, collateralized insurance investments and industry losses warranties. White Mountains Insurance Group, Ltd., was established in 1980. It is located in Hamilton, Bermuda.
Moving Average
White Mountains Insurance Group’s value is above its 50-day moving average of $1,305.18 and way above its 200-day moving average of $1,152.98.
Classification of Stock Prices
The stochastic oscillator is a helpful indicator for overbought or oversold situations.
White Mountains Insurance Group stock is oversold (=20).
Annual Top and Bottom Value
White Mountains Insurance Group stock was valued at $1.335.79 as of 18:23 EST. This is lower than the 52-week high $1,393.48, and much higher than its low 52-week of $978.51.
More news about White Mountains Insurance Group.
26. Eli Lilly and Company (LLY)
Shares of Eli Lilly and Company rose 8.73% in from $332.75 to $361.80 at 18:21 EST on Friday, after two consecutive sessions in a row of gains. NYSE is rising 0.56% to $15,309.77, after two successive sessions in a row of losses.
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Annual Top and Bottom Value
Eli Lilly and Company stock was valued at $361.80 as of 18:23 EST. This is below the 52-week high at $369.80 and well above its 52 week low at $231.87.
More news about Eli Lilly and Company.
27. TE Connectivity (TEL)
Shares of TE Connectivity jumped by a staggering 13.19% in from $111.91 to $126.67 at 18:21 EST on Friday, after four consecutive sessions in a row of losses. NYSE is jumping 0.56% to $15,309.77, after two sequential sessions in a row of losses.
TE Connectivity Ltd., together with its subsidiaries, manufactures and sells connectivity and sensor solutions in Europe, the Middle East, Africa, the Asia–Pacific, and the Americas. The company operates through three segments: Transportation Solutions, Industrial Solutions, and Communications Solutions. The Transportation Solutions segment provides terminals and connector systems and components, sensors, relays, antennas, heat shrink tubing, and application tooling products for use in the automotive, commercial transportation, and sensor markets. The Industrial Solutions segment offers terminals and connector systems and components; and heat shrink tubing, interventional medical components, relays, and wires and cables for aerospace, defense, oil and gas, industrial equipment, medical, and energy markets. The Communications Solutions segment supplies electronic components, such as terminals and connector systems and components, relays, heat shrink tubing, and antennas for the data and devices, and appliances markets. TE Connectivity Ltd. sells its products to approximately 140 countries primarily through direct sales to manufacturers, as well as through third-party distributors. The company was formerly known as Tyco Electronics Ltd. and changed its name to TE Connectivity Ltd. in March 2011. TE Connectivity Ltd. was incorporated in 2000 and is based in Schaffhausen, Switzerland.
Sales Growth
TE Connectivity has experienced 10.8% sales growth in the most recent quarter.
Annual Top and Bottom Value
TE Connectivity stock was valued at $126.67 as of 18:23 EST. This is way lower than the 52-week peak of $166.44, and much higher than the 52-week low at $104.76.
Moving Average
TE Connectivity’s worth is higher than its 50-day moving average of $117.85 and higher than its 200-day moving average of $125.89.
More news about TE Connectivity.